SCHEMBL13428447

SCHEMBL13428447

C1=Cc2ccccc2N(c2ccc3c(-c4cc5ccccc5c5ccccc45)c4cc(N5c6ccccc6C=Cc6ccccc65)ccc4c(-c4ccc5ccccc5c4)c3c2)c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.34
HSP90AA1 P07900 1/20 0.33
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
HIF1A Q16665 1/20 0.32
SOS1 Q07889 1/20 0.30
ALOX5 P09917 1/20 0.30
GSTP1 P09211 1/20 0.30
P2RX4 Q99571 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428405 0.91 ALDH1A1 (0.34) HSP90AA1MEN1USP2ALDH1A1LMNA
SCHEMBL13009207 0.91 HSP90AA1 (0.40) HSP90AA1ALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL13009244 0.91 HSP90AA1 (0.40) HSP90AA1ALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL13008888 0.89 POLB (0.35) HSP90AA1SOS1GSTP1P2RX4
SCHEMBL13009417 0.87 HSP90AA1 (0.37) HSP90AA1MEN1ALDH1A1TP53CYP1A2
SCHEMBL13428342 0.87 HSP90AA1 (0.37) HSP90AA1MEN1ALDH1A1TP53CYP1A2
SCHEMBL13428429 0.87 PIM1 (0.36) HSP90AA1P2RX4
SCHEMBL13009135 0.86 AKT1 (0.40) GPR84HSP90AA1SOS1ALOX5GSTP1
SCHEMBL13008883 0.86
SCHEMBL13428427 0.86 HSP90AA1 (0.36) HSP90AA1MEN1ALDH1A1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A GPR84 1648/4885HSP90AA1 4086/4885MEN1 3994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.